Financial comparisons ResMed, Inc.
Equities
RMD
US7611521078
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 207.78 USD | +1.78% |
|
+4.54% | -13.74% |
| 05-18 | Apnimed's sleep apnea pill meets main goal in late-stage study | RE |
| 05-11 | Resmed Insider Sold Shares Worth $1,037,233, According to a Recent SEC Filing | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 5.15B | 27.22% | 34.26% | 25.97% | 18.7% | -0.29x | ||
| 44.56B | 15.05% | 22.69% | 16.79% | 8.32% | 2.65x | ||
| 10.06B | 28.38% | 37.36% | 16.57% | 14.57% | -0.77x | ||
| 24.57B | 14.71% | 28.24% | 10.94% | 4.49% | 1.8x | ||
| 20.07B | 14.44% | 27.96% | 19.89% | 11.01% | 1.59x | ||
| 6.07B | 17.69% | 27.09% | 14.73% | 11.2% | -2.02x | ||
| 27.43B | 9.17% | 16.49% | 14.77% | 5.92% | 2.84x | ||
| 3.17B | 20.3% | 30.47% | 29.28% | 13.34% | 0.62x | ||
| 6.95B | 18.75% | 25.66% | 25.19% | 12.96% | 0.8x | ||
| 4.76B | 24.44% | 29.43% | 22% | 14.04% | -1.53x | ||
| 20.62B | 10.1% | 15.3% | 22.14% | 5.95% | 1.47x | ||
| 20.94B | 5.02% | 12.31% | 13.12% | 5.39% | 1.74x | ||
| 4.34B | 19.57% | 23.12% | 29.67% | 11.68% | 0.29x | ||
| 6.66B | 11.82% | 16.29% | 15.6% | 10.72% | -0.1x | ||
| 2.86B | 8.45% | 27.08% | 7.91% | 4.8% | 2.73x | ||
| 3.44B | -0.65% | 12.6% | 13.02% | 4.62% | 2.95x | ||
| 397M | -7.99% | -9.51% | -2.86% | -2.31% | -6.4x | ||
| 1.85B | 5.55% | 11.94% | 13.41% | 6.96% | - | ||
| 232M | 17.42% | 20.01% | 7.82% | 7.9% | - | ||
| 2.61B | 6.34% | 10.02% | 6.6% | 4.16% | 0.79x | ||
| Average | 10.84B | 13.29% | 20.94% | 16.13% | 8.72% | 0.51x | |
| Weighted average by Cap. | 19.89B | 17.58% | 26.78% | 17.42% | 9.99% | 0.95x |
- Stock Market
- Equities
- RMD Stock
- Sector ResMed, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















